Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
1.
J Med Genet ; 46(2): 94-102, 2009 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-18835858

RESUMEN

BACKGROUND: Fragile X syndrome (FXS) is the most common single gene inherited form of mental retardation, with behaviours at the extreme of the autistic spectrum. Subjects with FXS and fragile X mental retardation gene knock out (Fmr1 KO) mice, an animal model for FXS, have been shown to exhibit defects in dendritic spine maturation that may underlie cognitive and behavioural abnormalities in FXS. Minocycline is a tetracycline analogue that has been used in clinical trials for stroke, multiple sclerosis and several neurodegenerative conditions. METHODS: We evaluated the effects of minocycline on dendritic spine development in the hippocampus of young Fmr1 KO mice, and in primary cultures of hippocampal neurons isolated from those mice. Cognitive effects of minocycline in young WT and Fmr1 KO mice were also evaluated using established behavioural tests for general cognition, activity and anxiety. RESULTS: Our studies demonstrate that minocycline promotes dendritic spine maturation both in cultures and in vivo. The beneficial effects of minocycline on dendritic spine morphology are also accompanied by changes in the behavioural performance of 3-week-old Fmr1 KO mice. Minocycline treated Fmr1 KO mice show less anxiety in the elevated plus maze and more strategic exploratory behaviour in the Y maze as compared to untreated Fmr1 KO mice. Our data suggest that these effects of minocycline may relate to its inhibitory action on MMP-9 expression and activity, which are higher in the hippocampus of Fmr1 KO mice. CONCLUSION: These findings establish minocycline as a promising therapeutic for the treatment of fragile X mental retardation.


Asunto(s)
Espinas Dendríticas/efectos de los fármacos , Síndrome del Cromosoma X Frágil/tratamiento farmacológico , Minociclina/farmacología , Animales , Conducta Animal/efectos de los fármacos , Espinas Dendríticas/metabolismo , Modelos Animales de Enfermedad , Proteína de la Discapacidad Intelectual del Síndrome del Cromosoma X Frágil/genética , Proteína de la Discapacidad Intelectual del Síndrome del Cromosoma X Frágil/metabolismo , Síndrome del Cromosoma X Frágil/genética , Síndrome del Cromosoma X Frágil/metabolismo , Técnicas de Inactivación de Genes , Hipocampo/enzimología , Hipocampo/metabolismo , Metaloproteinasa 9 de la Matriz/metabolismo , Ratones , Minociclina/uso terapéutico , Actividad Motora , Neuronas
2.
Biochim Biophys Acta ; 1541(3): 231-8, 2001 Dec 19.
Artículo en Inglés | MEDLINE | ID: mdl-11755217

RESUMEN

Ligand binding to tumor necrosis factor receptor-I (TNFRI) can promote cell survival or activate the apoptotic caspase cascade. Cytoplasmic interaction of TNFRI with TRAF2 and RIP allows for the activation of JNK and NFkappaB pathways. Alternatively, a carboxy terminal death domain protein interaction motif can recruit TRADD, which then recruits FADD/MORT1, and finally procaspase 8. Aggregation of these components form a death inducing signaling complex, leading to the cleavage and activation of caspase 8. We have found that during apoptosis human TNFRI protein is lost in a caspase-dependent manner. The cytoplasmic tail of human TNFRI was found to be susceptible to caspase cleavage but not by caspase 8. Instead, the downstream executioner caspase 7 was the only caspase capable of cleaving TNFRI, in vitro. Identification and characterization of the cleavage site revealed a derivative of the classic EXD motif that incorporates a glutamate (E) in the P1 position. Using several criteria to establish that caspase activity was responsible for cleavage at this site, we confirmed that caspase 7 can cleave at a GELE motif. Mutation of the cleavage site prevented the apoptosis-associated cleavage of TNFRI. This ability of caspase 7 to cleave at a non-EXD or -DXXD motif suggests that the specificity of caspases may be broader than is currently held.


Asunto(s)
Antígenos CD/metabolismo , Caspasas/farmacología , Receptores del Factor de Necrosis Tumoral/metabolismo , Secuencia de Aminoácidos , Antígenos CD/química , Antígenos CD/genética , Apoptosis , Sitios de Unión , Caspasa 7 , Activación Enzimática , Humanos , Células Jurkat , Datos de Secuencia Molecular , Mutación , Plásmidos , Receptores del Factor de Necrosis Tumoral/química , Receptores del Factor de Necrosis Tumoral/genética , Receptores Tipo I de Factores de Necrosis Tumoral , Alineación de Secuencia , Transducción de Señal , Transfección
3.
J Mol Neurosci ; 15(1): 19-29, 2000 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-11211234

RESUMEN

The signaling pathways invoked by ligand binding to the common neurotrophin receptor p75NTR are incompletely understood. Using the yeast two-hybrid system, we identified the mitogen-activated protein (MAP) kinase p38beta2 as a specific interactor with the 5th and 6th alpha helices of the p75NTR intracytoplasmic region. The consequences of this interaction were studied, using primary cultures of Schwann cells and the 293T cell line. Phosphorylation of p75NTR by p38beta2 was induced in vitro and in vivo by MAP kinase kinases (MKK) 6 activation. This pathway demonstrated feedback in that nerve growth factor (NGF) binding increased p38beta2 activity, causing an increase of nuclear factor-kappaB (NF-kappaB) activation and a decrease of AP-1 activation. The mechanisms described explain at least in part why NGF binding to p75NTR increases cell survival in certain circumstances.


Asunto(s)
Apoptosis/fisiología , Sistema de Señalización de MAP Quinasas/fisiología , Proteínas Quinasas Activadas por Mitógenos/metabolismo , FN-kappa B/metabolismo , Receptor de Factor de Crecimiento Nervioso/metabolismo , Factor de Transcripción AP-1/metabolismo , Animales , Supervivencia Celular/efectos de los fármacos , Supervivencia Celular/fisiología , Células Cultivadas/efectos de los fármacos , Células Cultivadas/metabolismo , Dimerización , Humanos , Proteína Quinasa 11 Activada por Mitógenos , Factor de Crecimiento Nervioso/farmacología , Fosforilación , Estructura Terciaria de Proteína/fisiología , Ratas , Células de Schwann/efectos de los fármacos , Células de Schwann/metabolismo , Levaduras/metabolismo
4.
Restor Neurol Neurosci ; 2(3): 137-54, 1991 Jan 01.
Artículo en Inglés | MEDLINE | ID: mdl-21551594

RESUMEN

The purpose of this study was to determine the developmental stage of the chick embryo when descending spinal tracts lose the capacity for anatomical and functional repair after complete transection of the thoracic spinal cord. Previous studies have demonstrated that the first reticulospinal projections descend to the lumbar cord by embryonic day (E) 5. A comparison of the distribution and density of retrogradely labelled brainstem-spinal neurons in embryos versus hatchling chicks suggests that the descent of all brainstem-spinal projections is essentially complete to lumbar levels between E10 and El2. Transections and control sham operations were performed on different embryos from E3 through E14 of development. After a recovery period of 5-18 days, the extent of anatomical repair was assessed by injecting a small volume of a retrograde tract-tracing chemical into the upper lumbar spinal cord, caudal to the transection site. The brainstem nuclei were then examined for the number and distribution of retrogradely labelled brainstem-spinal neurons. In comparison to control animals, anatomical recovery appeared to be complete for embryos transected as late as E12, whereas thoracic cord transections conducted on E13-E14 resulted in reduced labelling of most brainstem-spinal nuclei. In addition, a number of E3-E6 transected embryos were allowed to hatch and with some assistance a few E7-E14 transected embryos also hatched. Functional recovery was assessed by behavioral observations and by focal electrical stimulation of brainstem locomotor regions (known to have direct projections to the lumbar spinal cord). Brainstem stimulation experiments were undertaken on transected and control embryos, either in ovo on E18-E20 or after hatching. Leg and wing muscle electromyographic recordings were used to monitor any brainstem evoked motor activity. Voluntary open-field locomotion (hatchling chicks) or brainstem evoked locomotion (embryonic or hatchling) in animals transected on or before E12 was indistinguishable from that observed in control (i.e. sham-operated or unoperated) chicks, indicating that complete functional recovery had occurred. In contrast, chicks transected on or after El3 showed reduced functional recovery. Since a previous study has shown that neurogenesis in chick brainstem-spinal neurons is complete prior to E5, the possible intrinsic neuronal mechanisms underlying the repair of descending supraspinal pathways are: (1) subsequent projections from later developing (undamaged) neurons, or (2) regrowth of previously axotomized projections (regeneration). For the E5-E12 chick embryos examined in this study, significant descending supraspinal fibers are present within the thoracic cord at the time of transection. Even if the transection is made at E12, when descending projections have completed their development to the lumbar cord, there is still a similar number and distribution of brainstem-spinal neurons labelled afterward (when compared to controls). This suggests that regeneration of previously axotomized projections may account for some of the observed anatomical and functional repair of brainstem-spinal pathways.

5.
Brain Res Dev Brain Res ; 76(2): 163-9, 1993 Dec 17.
Artículo en Inglés | MEDLINE | ID: mdl-8149582

RESUMEN

In this study we examined protein changes accompanying a developmental loss of axon regeneration in the spinal cord occurring around embryonic day 13 (E13) of spinal cord development in the chick. We employed high resolution two-dimensional (2D) gel electrophoresis to identify proteins consistently altering their expression around this critical period. Spinal cord protein fractions were isolated from E8, E10, E12, E14, E16, E18 and post-hatching day 2 spinal cord and separately run on a high resolution 2D gel system. Protein spots were visualized with silver staining and subsequently analyzed. Ten proteins were identified, termed developmental spinal cord proteins (DSPs), with five increasing and five decreasing their abundance over the developmental period studied. Apparent molecular weight and isoelectric points have been calculated and are reported. Further studies, currently underway, will be required to determine if these identified proteins are involved in the developmental loss of regenerative ability.


Asunto(s)
Regeneración Nerviosa/fisiología , Proteínas del Tejido Nervioso/biosíntesis , Médula Espinal/fisiología , Secuencia de Aminoácidos , Animales , Embrión de Pollo , Médula Espinal/embriología
6.
Brain Res Dev Brain Res ; 72(1): 1-8, 1993 Mar 19.
Artículo en Inglés | MEDLINE | ID: mdl-8453760

RESUMEN

Recent studies of spinal cord development and plasticity, in chick, have demonstrated a loss of regenerative ability correlating to embryonic day (E) 13 of the 21-day developmental period. Here we describe membrane fractions from embryonic chick spinal cords as permissive or restrictive substrates for the neuron-like differentiation of neuroblastoma x glioma hybrid NG108-15 cells, in vitro. Plasma membranes were purified from the thoracic spinal cord of embryos at a series of developmental stages (E10-E18). Micro-well plates were coated with the fractions and NG108-15 cells cultured thereon. Cells adhered to the E10-coated wells and began to differentiate after 2 h, becoming highly differentiated, with neurites 2-3 times longer than the diameter of the cell body after 24 h in in culture. In contrast, cells cultured in E18-coated wells remained as clusters of undifferentiated cells of rounded morphology, even after 48 h in culture. As well, the permissive and restrictive plasma membranes were assessed semiquantitatively as the number of adhering cells after 20 h of culture. Adhesion of cells to the substrate decreased as the embryonic age of the plasma membrane substrate increased. Examination of the plasma membrane fractions, using SDS-PAGE, revealed several proteins in the 40-60 kDa range that varied substantially between E12, E14 and E18. Results of this study provide in vitro confirmation of previous in vivo findings; namely, that early embryonic spinal cord is initially permissive for neuritic outgrowth becoming restrictive around E13.(ABSTRACT TRUNCATED AT 250 WORDS)


Asunto(s)
Diferenciación Celular , Membrana Celular/fisiología , Médula Espinal/embriología , Animales , Diferenciación Celular/efectos de los fármacos , Fraccionamiento Celular , Membrana Celular/ultraestructura , Embrión de Pollo , Electroforesis en Gel de Poliacrilamida , Glioma , Células Híbridas/citología , Proteínas de la Membrana/aislamiento & purificación , Proteínas de la Membrana/farmacología , Peso Molecular , Proteínas del Tejido Nervioso/aislamiento & purificación , Proteínas del Tejido Nervioso/farmacología , Neuritas/efectos de los fármacos , Neuritas/fisiología , Neuritas/ultraestructura , Neuroblastoma , Células Tumorales Cultivadas
7.
Transl Psychiatry ; 4: e414, 2014 Jul 29.
Artículo en Inglés | MEDLINE | ID: mdl-25072319

RESUMEN

Adaptive immunity to self-antigens causes autoimmune disorders, such as multiple sclerosis, psoriasis and type 1 diabetes; paradoxically, T- and B-cell responses to amyloid-ß (Aß) reduce Alzheimer's disease (AD)-associated pathology and cognitive impairment in mouse models of the disease. The manipulation of adaptive immunity has been a promising therapeutic approach for the treatment of AD, although vaccine and anti-Aß antibody approaches have proven difficult in patients, thus far. CD4(+) T cells have a central role in regulating adaptive immune responses to antigens, and Aß-specific CD4(+) T cells have been shown to reduce AD pathology in mouse models. As these cells may facilitate endogenous mechanisms that counter AD, an evaluation of their abundance before and during AD could provide important insights. Aß-CD4see is a new assay developed to quantify Aß-specific CD4(+) T cells in human blood, using dendritic cells derived from human pluripotent stem cells. In tests of >50 human subjects Aß-CD4see showed an age-dependent decline of Aß-specific CD4(+) T cells, which occurs earlier in women than men. In aggregate, men showed a 50% decline in these cells by the age of 70 years, but women reached the same level before the age of 60 years. Notably, women who carried the AD risk marker apolipoproteinE-ɛ4 (ApoE4) showed the earliest decline, with a precipitous drop between 45 and 52 years, when menopause typically begins. Aß-CD4see requires a standard blood draw and provides a minimally invasive approach for assessing changes in Aß biology that may reveal AD-related changes in physiology by a decade. Furthermore, CD4see probes can be modified to target any peptide, providing a powerful new tool to isolate antigen-specific CD4(+) T cells from human subjects.


Asunto(s)
Inmunidad Adaptativa/inmunología , Enfermedad de Alzheimer/inmunología , Péptidos beta-Amiloides/inmunología , Apolipoproteína E4/sangre , Recuento de Linfocito CD4 , Inmunidad Adaptativa/genética , Anciano , Anciano de 80 o más Años , Enfermedad de Alzheimer/diagnóstico , Enfermedad de Alzheimer/genética , Péptidos beta-Amiloides/genética , Apolipoproteína E4/genética , Células Dendríticas/inmunología , Progresión de la Enfermedad , Células Madre Embrionarias/inmunología , Femenino , Genotipo , Humanos , Masculino , Persona de Mediana Edad , Células Madre Pluripotentes , Factores Sexuales
8.
Neuroscience ; 246: 186-98, 2013 Aug 29.
Artículo en Inglés | MEDLINE | ID: mdl-23660195

RESUMEN

Fragile X Syndrome (FXS) is the most common single-gene inherited form of intellectual disability with behaviors characteristic of autism. People with FXS display childhood seizures, hyperactivity, anxiety, developmental delay, attention deficits, and visual-spatial memory impairment, as well as a propensity for obsessive-compulsive disorder. Several of these aberrant behaviors and FXS-associated synaptic irregularities also occur in "fragile X mental retardation gene" knock-out (Fmr1 KO) mice. We previously reported that minocycline promotes the maturation of dendritic spines - postsynaptic sites for excitatory synapses - in the developing hippocampus of Fmr1 KO mice, which may underlie the beneficial effects of minocycline on anxiolytic behavior in young Fmr1 KO mice. In this study, we compared the effectiveness of minocycline treatment in young and adult Fmr1 KO mice, and determined the dependence of behavioral improvements on short-term versus long-term minocycline administration. We found that 4- and 8-week-long treatments significantly reduced locomotor activity in both young and adult Fmr1 KO mice. Some behavioral improvements persisted in young mice post-treatment, but in adults the beneficial effects were lost soon after minocycline treatment was stopped. We also show, for the first time, that minocycline treatment partially attenuates the number and severity of audiogenic seizures in Fmr1 KO mice. This report provides further evidence that minocycline treatment has immediate and long-lasting benefits on FXS-associated behaviors in the Fmr1 KO mouse model.


Asunto(s)
Proteína de la Discapacidad Intelectual del Síndrome del Cromosoma X Frágil/genética , Síndrome del Cromosoma X Frágil/tratamiento farmacológico , Síndrome del Cromosoma X Frágil/genética , Minociclina/uso terapéutico , Actividad Motora/efectos de los fármacos , Factores de Edad , Animales , Animales Recién Nacidos , Proteína de la Discapacidad Intelectual del Síndrome del Cromosoma X Frágil/metabolismo , Síndrome del Cromosoma X Frágil/metabolismo , Aprendizaje por Laberinto/efectos de los fármacos , Aprendizaje por Laberinto/fisiología , Ratones , Ratones de la Cepa 129 , Ratones Noqueados , Minociclina/farmacología , Actividad Motora/fisiología , Factores de Tiempo , Resultado del Tratamiento
10.
Exp Neurol ; 128(2): 233-8, 1994 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-8076667

RESUMEN

Proteoglycan (PG) biosynthesis in vivo and PG-associated neurite growth-promoting activity in vitro were examined in the thoracic spinal cord of embryonic chick at times during which functional recovery following axonal damage is permitted, and at later times when such functional recovery is restricted. Over a 10-day period encompassing the permissive and restrictive periods the ratio of newly synthesized heparan sulfate (HS) PG to chondroitin sulfate (CS) PG decreased by more than 50%. Specific PG-associated neurite-promoting activity (NPA) of a PG fraction immobilized on a laminin substrate was 75-fold higher at E9 than at E17. Perturbations of the two families of PGs indicated that all laminin-bound NPA was associated with HSPGs from E9 cord, and that removal of the influence of CSPGs from PG extracts of E17 cord unmasked neurite-promoting activity on a poly-D-lysine substrate of the same magnitude as that observed on a laminin substrate. Neurite-promoting activity associated with HSPGs and high HS to CS ratios of newly synthesized PGs characterize the permissive period for axonal regeneration in the chick embryo spinal cord. In the restrictive period for axonal regeneration neurite promoting activity is masked by the presence of CSPGs which are synthesized at higher levels than HSPGs.


Asunto(s)
Proteoglicanos Tipo Condroitín Sulfato/fisiología , Heparitina Sulfato/fisiología , Regeneración Nerviosa , Proteoglicanos/fisiología , Médula Espinal/embriología , Animales , Bioensayo , Embrión de Pollo , Desarrollo Embrionario y Fetal , Proteoglicanos de Heparán Sulfato , Laminina , Neuritas/fisiología , Polilisina , Tórax
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA